REUTERS NEXT-Genentech CEO says its flu medicine headed to TrumpRx

NEW YORK, March 16 (Reuters) - Roche's ROG.S Genentech unit's Chief Executive Ashley Magargee said on Monday that the company's Xofluza flu drug will be on the government's TrumpRx.gov website when the administration launches the next tranche of medicines there.

The drug is now available directly to patients on its own website for patients paying in cash for $50, a distribution channel the company says it sees as amenable to oral drugs rather than physician-assisted medicines.

"We're certainly experimenting and bringing many more through that channel than we ever have," said Magargee, speaking at the Reuters Pharma USA 2026 event in Philadelphia.